The Technical Analyst
Select Language :
Anthem Inc. Corporate [ANTX]

Exchange: NYSE Sector: Healthcare Industry: Biotechnology

Anthem Inc. Corporate Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Anthem Inc. Corporate is listed at the  Exchange

4.05% $3.35

America/New_York / 28 mar 2024 @ 13:57


Anthem Inc. Corporate: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 99.63 mill
EPS: -2.80
P/E: -1.200
Earnings Date: Mar 28, 2024
SharesOutstanding: 29.74 mill
Avg Daily Volume: 0.414 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.200 | sector: PE 15.43
PE RATIO: COMPANY / INDUSTRY
-0.03x
Company: PE -1.200 | industry: PE 40.47
DISCOUNTED CASH FLOW VALUE
$1.771
(-47.14%) $-1.579
Date: 2024-03-28
Expected Trading Range (DAY)

$ 2.56 - 4.08

( +/- 22.80%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-15 Day Lucy Buy 55 000 Stock Option (right to buy)
2024-03-15 Day Lucy Buy 27 500 Common Stock
2024-03-15 Eizen Joshua M Buy 60 000 Stock Option (right to buy)
2024-03-15 Eizen Joshua M Buy 30 000 Common Stock
2024-03-15 Krause Kevin Michael Buy 60 000 Stock Option (right to buy)
INSIDER POWER
65.21
Last 100 transactions
Buy: 3 419 514 | Sell: 646 406

Forecast: 15:36 - $3.33

Live Trading Signals (every 1 min)

Forecast 1: 14:06 - $3.35
Forecast 2: 14:56 - $3.31
Forecast 3: 15:36 - $3.33
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.35 (4.05% )
Volume 0.103 mill
Avg. Vol. 0.414 mill
% of Avg. Vol 24.89 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Anthem Inc. Corporate Units

Last 12 Months

Last 12 months chart data with high, low, open and close for Anthem Inc. Corporate Units

RSI

Intraday RSI14 chart for Anthem Inc. Corporate Units

Last 10 Buy & Sell Signals For ANTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35buy$20.00N/AActive
Profile picture for
            Anthem Inc. Corporate Units

ANTX

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

Last 10 Buy Signals

Date Signal @
UNFIUSDMar 28 - 13:547.44
WOOUSDMar 28 - 13:54$0.455
SFPUSDMar 28 - 13:54$0.777
POLSUSDMar 28 - 13:54$1.220
BARUSDMar 28 - 13:543.65
CREAMUSDMar 28 - 13:5429.76
NTRAMar 28 - 13:54$90.98
CTASMar 28 - 13:54$682.38
NEXOUSDMar 28 - 13:531.331
PAASMar 28 - 13:50$15.06

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.